Advertisement
Screener

Amylyx Pharmaceuticals, Inc. (AMLX) ROA

Amylyx Pharmaceuticals, Inc. (AMLX) ROA

  • 2026-06-30: ROA -57.49%.
  • 2026-03-31: ROA -51.13%.
  • 2025-12-31: ROA -43.51%.
  • 2025-09-30: ROA -41.15%.

Complete source-backed roa history.

Available history
2021-12-31 to 2026-06-30
Data captured

Historical ROA

DateROA
2026-06-30-57.49%
2026-03-31-51.13%
2025-12-31-43.51%
2025-09-30-41.15%
2025-06-30-96.40%
2025-03-31-99.63%
2024-12-31-155.83%
2024-09-30-103.49%
2024-06-30-49.94%
2024-03-31-17.03%
2023-12-319.52%
2023-09-300.39%
2023-06-30-16.05%
2023-03-31-36.51%
2022-12-31-50.68%
2022-09-30-101.42%
2022-06-30-68.11%
2022-03-31-44.18%
2021-12-31-83.26%

Annual ROA

DateROA
2025-12-31-43.51%
2024-12-31-155.83%
2023-12-319.52%
2022-12-31-50.68%
2021-12-31-83.26%

Similar stocks

Stock NameCountryMarket CapPE Ratio
Enliven Therapeutics, Inc. (ELVN)United States$3.307B-35.07
Arcutis Biotherapeutics, Inc. (ARQT)United States$3.303B115.47
Arcus Biosciences, Inc. (RCUS)United States$3.188B-8.52
IDEAYA Biosciences, Inc. (IDYA)United States$3.540B-20.52
Organon & Co. (OGN)United States$3.603B17.03
Dyne Therapeutics, Inc. (DYN)United States$3.084B-7.09
Xenon Pharmaceuticals Inc. (XENE)$3.684B-14.27
ACADIA PHARMACEUTICALS INC (ACAD)United States$3.823B11.45
AbCellera Biologics Inc. (ABCL)$3.879B-14.59
PRECIGEN, INC. (PGEN)United States$2.757B-12.94